for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

American Renal Associates Holdings Inc

ARA

Latest Trade

8.92USD

Change

-0.01(-0.11%)

Volume

97,679

Today's Range

8.77

 - 

9.04

52 Week Range

5.48

 - 

17.31

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.93
Open
9.03
Volume
97,679
3M AVG Volume
5.30
Today's High
9.04
Today's Low
8.77
52 Week High
17.31
52 Week Low
5.48
Shares Out (MIL)
32.61
Market Cap (MIL)
289.89
Forward P/E
-18.52
Dividend (Yield %)
--

Next Event

American Renal Associates Holdings Inc Annual Shareholders Meeting

Latest Developments

More

American Renal Associates Holdings Announces Q3 2019 Results

American Renal Issues Statement Regarding Executive Order Related To Advancing American Kidney Health Initiative

American Renal Associates HoldingsSecures Amendment And Waiver Under Credit Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About American Renal Associates Holdings Inc

American Renal Associates Holdings, Inc. is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia. The Company operates its dialysis clinics exclusively through a JV model, in which it partners primarily with local nephrologists to develop, own and operate dialysis clinics, while the providers of the majority of dialysis services in the United States operate through a combination of subsidiaries and joint ventures. It provides patient care and clinical outcomes to patients suffering from end-stage renal disease (ESRD). Its clinics offer both in center and home dialysis options to meet the needs of patients. Its clinics primarily provide in center hemodialysis treatments and ancillary items and services.

Industry

Healthcare Facilities

Contact Info

American Renal Holdings

Inc., 500 Cummings Center, Suite 6550

+1.978.9223080

http://ir.americanrenal.com/

Executive Leadership

Joseph A. Carlucci

Chairman of the Board, Chief Executive Officer, Co-Founder

Syed T. Kamal

President, Co-Founder, Director

Mark Herbers

Interim Chief Financial Officer, Interim Chief Accounting Officer

Don Williamson

Chief Operating Officer, Executive Vice President

Michael E. Boxer

Independent Director

Key Stats

3.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.7K

2017

0.7K

2018

0.8K

2019(E)

0.8K
EPS (USD)

2016

1.170

2017

0.610

2019(E)

-0.480
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.36
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
6.28
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
0.95
Return on Equity (TTM)
0.50

Latest News

Latest News

BRIEF-American Renal Associates Holdings Reports Q1 Adjusted Earnings Per Share $0.11

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS

BRIEF-United Healthcare Insurance Co And United Healthcare Services Files Complaint Against American Renal Associates

* ON MARCH 30, UNITED HEALTHCARE INSURANCE CO AND UNITED HEALTHCARE SERVICES FILED A COMPLAINT AGAINST UNITS

BRIEF-American Renal Associates Holdings Qtrly EPS $0.05

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FOURTH QUARTER 2017 RESULTS

BRIEF-American Renal Associates Settles Shareholder Class Action Litigation

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES SETTLEMENT OF SHAREHOLDER CLASS ACTION LITIGATION

BRIEF-American Renal Associates Holdings reports adj. EPS $0.19

* Q3 earnings per share view $0.16 -- Thomson Reuters I/B/E/S

BRIEF-American Renal Associates reports Q2 adj earnings per share $0.16

* American Renal Associates Holdings Inc announces second quarter 2017 results

BRIEF-American Renal Associates Holdings files for possible resale by selling stockholders of up to 19 million shares - SEC filing

* American Renal Associates Holdings files for possible resale by selling stockholders of up to 19 million shares of common stock - SEC filing Source text: (http://bit.ly/2uuHLKp) Further company coverage:

BRIEF-American Renal Associates Holdings Inc says units entered into credit agreement

* American Renal Associates Holdings Inc - on june 22, units entered into a credit agreement - SEC filing

BRIEF-American Renal Associates Holdings announces Q1 loss per share $0.40

* American Renal Associates Holdings, Inc. announces first quarter 2017 results

BRIEF-American Renal Associates Holdings Q4 adjusted EPS $0.26

* American Renal Associates Holdings, Inc. announces fourth quarter 2016 results

BRIEF-American Renal Associates Holdings receives a subpoena from U.S. Department of justice

* American Renal Associates Holdings - on January 3, 2017, company received a subpoena from U.S. Department of justice ('doj'), dated December 30, 2016

BRIEF-American Renal Associates Q3 adjusted EPS $0.28

* American renal associates holdings inc qtrly net patient service operating revenues increased 15% to $193.0 million

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up